Two-year chemical carcinogenesis studies using rodents are the major bioassay for identifying environmental carcinogens (1) (2) (3) . Due largely to the limited number of animals per test (generally 50-60 animals of each sex of two species, rats and mice, in each experimental group), bioassays are conducted at relatively high exposure concentrations to optimize the probability of detecting a carcinogenic response. These long-term bioassays were originally designed primarily for qualitative identification of potential human carcinogens, so that further studies could be done as necessary to elucidate dose-response relationships for quantitative risk assessment. Unfortunately, subsequent experiments are often not possible due to limited resources and the need to test other chemicals; thus, carcinogenesis bioassay data are frequently used for quantitative risk assessments, despite potential limitations and confounding factors (4).
Carcinogenesis bioassays have been criticized for identifying "too many rodent carcinogens" and are criticized as not predicting carcinogenic hazards to humans, largely because of purported differences in exposures and lack of discrimination due to high-dose effects (5) . Long-term bioassays are designed to expose rodents to chemicals or environmental mixtures that cause only minimal toxic effects. The highest dose selected for these studies has been termed the "maximum tolerated dose" (MTD), when, in fact, it actually represents a minimally toxic exposure dose (6) (7) (8) . Since nearly half the chemicals tested by the National Cancer Institute (NCI) (9) and the National Toxicology Program (NTP) (10) elicited a positive response in the rodent bioassays, some researchers have postulated that carcinogenesis in these studies results from cell killing and increased cell division (mitogenesis) (5) . However, no obvious correlation between toxicity and carcinogenicity exists (11) (12) (13) (14) . Mitogenesis is certainly crucial to the carcinogenic process (5, (15) (16) (17) (18) , but the conclusion that the majority of positive carcinogenesis responses results from cell killing and mitogenesis requires a more critical evaluation (11, 12, (17) (18) (19) Further analysis of the 181 positive chemicals that were suspect carcinogens showed that 42 were positive in only 1 of 4 sex-species groups, 70 in 2 groups (14 of these chemicals were positive in 2 species), 27 in 3 groups, and 42 in all 4 groups ( Table 2) . Thus, 83 (14 + 27 + 42) of the 267 suspect carcinogens tested were positive in 2 species and thus meet the international criteria to evaluate further for potential human cancer risk.
Only 29 of the 133 chemicals (22%) selected mainly on the basis of exposure considerations were positive in at least 1 of the 4 sex-species groups, 13 of these 29 chemicals were positive in only 1 sex-species group; 9 chemicals in 2 groups (2 of these chemicals were positive in 2 species), 4 chemicals in 3 groups, and 3 chemicals in all 4 experimental groups. Thus, 9 (24) (25) (26) (27) and need more detailed and extensive evaluation of the available data and information. 5 of these chemicals are in IARC group 1 ("agent is carcinogenic to humans"), 10 chemicals are in group 2A ("agent is probably carcinogenic to humans"), and 48 chemicals are in p-oup 2B ("agent is possibly carcinogenic to humans"). Sixty chemicals are listed by DHHS in the Annual Report on Carcinogens (ARC) as presenting carcinogenic hazards to humans: 4 chemicals are listed as "known to be carcinogenic to humans" (4 of the 5 in IARC) and 56 chemicals are listed as "reasonably anticipated to be a carcinogen to humans." For the majority of the chemicals there is excellent correspondence for listing by both IARC and in the ARC. The categories of evidence and names of the chemicals are provided in Tables 3 and 4. Sixty-eight of the 75 chemicals (9 1%) listed by IARC or in the ARCwere selected as suspect carcinogens, and 7 (9%) were selected on the basis of human exposure considerations. Fifty (68) 86 (32) 29(22) 104 (78) (55) 13 (24) 9 (11) 4 (13) 3 (7) 29 (14) Volume 103, Number 7-8, July-August 1995 beiecuon oasis course, exposure patterns and other necessary conditions must also be considered (28) (29) (30) . Our current review of the 400 chemicals tested in the bioassay program indicates that only 23% are positive in two species, and thus, using international criteria, these 92 chemicals may be considered for further evaluation as being most likely to pose carcinogenic risks to humans. However, because the majority of chemicals tested to date were selected as suspect carcinogens, this must be considered to be a high estimate. Only 6.8% of the chemicals selected on the basis of exposure/production volume may be considered as likely to pose carcinogenic risks to humans. Therefore, we predict that if all 75,000 chemicals in use were to be tested for carcinogenicity in the standard NTP bioassay, significantly less than 50% would be carcinogenic in animals, and even a smaller percentage (less than 5-10%) would need further evaluation (Huff et (25) . This public health statement has and should continue to be endorsed and used by those responsible for protecting human health. 
